Aegerion Pharmaceuticals
AEGR
AEGR was delisted on the 29th of November, 2016.
145 hedge funds and large institutions have $1.95B invested in Aegerion Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
106.09% more ownership
Funds ownership: 0% → 106.09% (+106%)
37% more call options, than puts
Call options by funds: $123M | Put options by funds: $90.3M
Top Buyers
Top Sellers
AEGR Hedge Fund Activity: Q2 2013 in Review
145 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Aegerion Pharmaceuticals (AEGR) for Q2 2013, worth a combined $1.95B.
Fund positioning in AEGR was balanced in Q2 2013: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
- 145 institutional investors held Aegerion Pharmaceuticals (AEGR) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $1.95B of Aegerion Pharmaceuticals stock for Q2 2013.
- 0 funds opened new Aegerion Pharmaceuticals positions in Q2 2013 and 0 closed out.
Based on aggregated 13F filings for Q2 2013.